Company Profile


InventisBio is a dynamic and fast-growing global biotech company with multiple therapeutic agents at clinical stage. InventisBio focuses on discovery and development of novel therapeutics in the areas of oncology and metabolic diseases to address unmet medical needs. The company was founded by a group of scientists with extensive R&D and management experience in global pharmaceutical companies. InventisBio's headquarter and R&D center are located in Pharma Valley of Shanghai Zhangjiang Hi-Tech Park, with a subsidiary in New Jersey, US as well. Currently, Inventisbio has four drug candidates in clinical development in both China and US targeting non-small cell lung cancer (NSCLC), breast cancer, colorectal cancer (CRC), and gout. The company’s philosophy is to exert the spirit of artisans in the discovery, development and delivery of high-quality and innovative therapies that benefit patients.


Management team

Yaolin Wang Ph.D.
Chairman and CEO
Ling Zhang M.D., Ph.D.
Chief Medical Officer
David Dai Ph.D.
Senior VP, R&D
Jack Jiang Ph.D.
Senior VP, R&D

Scientific Advisory Board

© 2019-2021 InventisBio Co., Ltd.